A carregar...
Interferon β-1a subcutaneously 3 times/week clinical outcome in relapsing multiple sclerosis in Finland
Prognostic factors and long-term treatment response of interferon β-1a s.c tiw has not been studied in a real-life clinical cohort in Finland. The aim of the paper was to evaluate long-term treatment response, prognostic clinical factors and adherence among interferon β-1a s.c tiw treated patients i...
Na minha lista:
| Publicado no: | Neurol Int |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
PAGEPress Publications, Pavia, Italy
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6908953/ https://ncbi.nlm.nih.gov/pubmed/31871598 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/ni.2019.8177 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|